Can cost-effectiveness results be combined into a coherent league table? Case study from one high-income country

Population Health Metrics
Nick WilsonTony Blakely

Abstract

Doubts exist around the value of compiling league tables for cost-effectiveness results for health interventions, primarily due to methods differences. We aimed to determine if a reasonably coherent league table could be compiled using published studies for one high-income country: New Zealand (NZ). Literature searches were conducted to identify NZ-relevant studies published in the peer-reviewed journal literature between 1 January 2010 and 8 October 2017. Only studies with the following metrics were included: cost per quality-adjusted life-year or disability-adjusted life-year or life-year (QALY/DALY/LY). Key study features were abstracted and a summary league table produced which classified the studies in terms of cost-effectiveness. A total of 21 cost-effectiveness studies which met the inclusion criteria were identified. There were some large methodological differences between the studies, particularly in the time horizon (1 year to lifetime) but also discount rates (range 0 to 10%). Nevertheless, we were able to group the incremental cost-effectiveness ratios (ICERs) into general categories of being reported as cost-saving (19%), cost-effective (71%), and not cost-effective (10%). The median ICER (adjusted to 2017 NZ$) was...Continue Reading

References

Jun 1, 1995·Risk Analysis : an Official Publication of the Society for Risk Analysis·T O TengsJ D Graham
Nov 4, 2000·Medical Decision Making : an International Journal of the Society for Medical Decision Making·R H ChapmanP J Neumann
Sep 18, 2003·PharmacoEconomics·Josephine MauskopfWarren Schonfeld
Aug 3, 2005·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Peter J NeumannMilton C Weinstein
Feb 24, 2006·BMJ : British Medical Journal·Chaim M BellPeter J Neumann
Feb 15, 2008·The New England Journal of Medicine·Joshua T CohenMilton C Weinstein
May 21, 2008·Cost Effectiveness and Resource Allocation : C/E·Kim DalzielDuncan Mortimer
Jan 9, 2010·Journal of the National Cancer Institute·Dan GreenbergPeter J Neumann
Feb 8, 2011·Journal of the Royal Society, Interface·Luis R CarrascoAlex R Cook
Feb 26, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Anthony HarrisDavid C Harris
Jun 23, 2011·Cost Effectiveness and Resource Allocation : C/E·Guy W ScottPhilippa H Gander
Sep 23, 2011·International Journal of Technology Assessment in Health Care·Elizaveta Sopina, Toni Ashton
Oct 21, 2011·International Journal of Stroke : Official Journal of the International Stroke Society·Braden J Te AoCraig S Anderson
Oct 17, 2012·Australian Journal of Primary Health·William LeungAsmita Patel
Nov 13, 2012·Child Abuse & Neglect·Joshua FriedmanPatrick Kelly
Mar 30, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Don HusereauUNKNOWN ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force
Nov 12, 2013·International Journal of Stroke : Official Journal of the International Stroke Society·Braden Te AoValery Feigin
Apr 20, 2014·Obesity Research & Clinical Practice·Elaine RushAdéle R Weston
Jun 28, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Richard J MilneHarry Rea
Apr 18, 2015·Bulletin of the World Health Organization·Elliot MarseilleSydney Rosen
Jun 18, 2016·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·Michael D KeallMichael G Baker
Aug 20, 2016·International Journal of Cancer. Journal International Du Cancer·Kate T SimmsKaren Canfell
May 11, 2017·Public Health Nutrition·Elisabeth SchorlingAnja Kroke

❮ Previous
Next ❯

Citations

Mar 28, 2020·International Journal of Environmental Research and Public Health·Nina van der VlietJohan J Polder

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

BODE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.